Claire Reiss, a major owner of Biocept, recently acquired 227,272 shares of the company. The buys took place at $1.10 per share, on October 19, 2016. Reiss now owns 1,051,285 shares of the company. Reiss operates out of San Diego, CA. Some additional info was provided as follows:
Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 1,638,675 fewer shares.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 9,340 fewer shares.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
Departure of Directors or Certain - Sept. 8, 2017
Biocept Just Received a Notice of Effectiveness - Aug. 30, 2017
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 30, 2017